To investigate whether C12orf59 expression is altered during carcinogenesis, we performed an in silico analysis of C12orf59 expression in human normal kidney tissues and ccRCC using microarray expression studies published in Oncomine(31). This evidence concerns the gene TMEM52B and nonpapillary renal cell carcinoma.